Transcriptomic integration reveals immune heterogeneity in vascular dementia and identifies ELF2 as a candidate therapeutic target.

Liang L, Shen C, Huang S, Hu M, Zhu J.

Open source

DOI
10.1097/md.0000000000050324
Published
2026-09-01
Container
Medicine (Baltimore)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000050324,
  title = {Transcriptomic integration reveals immune heterogeneity in vascular dementia and identifies ELF2 as a candidate therapeutic target.},
  author = {Liang L and  Shen C and  Huang S and  Hu M and  Zhu J.},
  year = {2026},
  journal = {Medicine (Baltimore)},
  doi = {10.1097/md.0000000000050324},
  url = {https://doi.org/10.1097/md.0000000000050324}
}

RIS

TY  - JOUR
TI  - Transcriptomic integration reveals immune heterogeneity in vascular dementia and identifies ELF2 as a candidate therapeutic target.
AU  - Liang L
AU  -  Shen C
AU  -  Huang S
AU  -  Hu M
AU  -  Zhu J.
PY  - 2026
JO  - Medicine (Baltimore)
DO  - 10.1097/md.0000000000050324
UR  - https://doi.org/10.1097/md.0000000000050324
ER  - 

APA

L, L., C, S., S, H., M, H., & J., Z. (2026). Transcriptomic integration reveals immune heterogeneity in vascular dementia and identifies ELF2 as a candidate therapeutic target.. Medicine (Baltimore). https://doi.org/10.1097/md.0000000000050324

Source records